1. World Health Organisation (2005) Global patient safety challenge: clean care is safer care. In: World Alliance for Patient Safety, editor. Geneva.
2. LivermoreDM (2003) Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 36: S11–23.
3. LambertML, SuetensC, SaveyA, PalomarM, HiesmayrM, et al. (2011) Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 11: 30–38.
4. LevinBR, BontenMJ (2004) Cycling antibiotics may not be good for your health. Proc Natl Acad Sci U S A 101: 13101–13102.
5. BergstromCT, LoM, LipsitchM (2004) Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A 101: 13285–13290.
6. BonhoefferS, LipsitchM, LevinBR (1997) Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci U S A 94: 12106–12111.
7. MastertonRG (2005) Antibiotic cycling: more than it might seem? J Antimicrob Chemother 55: 1–5.
8. MastertonRG (2010) Antibiotic heterogeneity. Int J Antimicrob Agents 36 Suppl 3: S15–18.
9. BrownEM, NathwaniD (2005) Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 55: 6–9.
10. BalAM, KumarA, GouldIM (2010) Antibiotic heterogeneity: from concept to practice. Ann N Y Acad Sci 1213: 81–91.
11. NijssenS, BootsmaM, BontenM (2006) Potential confounding in evaluating infection-control interventions in hospital settings: changing antibiotic prescription. Clin Infect Dis 43: 616–623.
12. de KrakerME, DaveyPG, GrundmannH (2011) Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 8: e1001104.
13. PaulM, KarivG, GoldbergE, RaskinM, ShakedH, et al. (2010) Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 65: 2658–2665.
14. VincentJL (2003) Nosocomial infections in adult intensive-care units. Lancet 361: 2068–2077.
15. DamasP, CanivetJL, LedouxD, MonchiM, MelinP, et al. (2006) Selection of resistance during sequential use of preferential antibiotic classes. Intensive Care Med 32: 67–74.
16. DominguezEA, SmithTL, ReedE, et al. (2000) A pilot study of antibiotic cycling in a haematology-oncology unit. Control and Hospital Epidemiology 21: S4–S8.
17. EvansHL, MilburnML, HughesMG, SmithRL, ChongTW, et al. (2005) Nature of gram-negative rod antibiotic resistance during antibiotic rotation. Surg Infect (Larchmt) 6: 223–231.
18. FranceticI, KalenicS, HuicM, MercepI, Makar-AuspergerK, et al. (2008) Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study. Croat Med J 49: 207–214.
19. GerdingDNL, TA (1985) Aminoglycoside resistance in gram-negative bacilli during increased amikacin use: comparison of experience in fourteen United States hospitals with experience in the Minneapolis Veterans Administration Medical Center. American Journal of Medicine 79, Suppl. 1A: 1–7.
20. HughesMG, EvansHL, ChongTW, et al. (2004) Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward. Critical Care Medicine 32: 53–60.
21. KollefMH, VlasnikJ, SharplessL, et al. (1997) Scheduled rotation of antibiotic classes. A strategy to decrease the incidence of ventilator-associated pneumonia due to antibiotic-resistant gramnegative bacteria. American Journal of Respiratory Critical Care Medicine 156: 1040–1048.
22. KollefMH, WardS, ShermanG, et al. (2000) Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Critical Care Medicine 28: 3456–3464.
23. MartinezJA, NicolásJM, MarcoF, et al. (2005) Comparison of antimicrobial cycling and mixing in two medical intensive care units. Critical Care Medicine 34: 329–336.
24. MartinezJA, DelgadoE, MartiS, MarcoF, VilaJ, et al. (2009) Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients. Intensive Care Med 35: 439–447.
25. PuzniakLA, MayfieldJ, LeetT, et al. (2001) Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clinical Infectious Diseases 33: 151–157.
26. RaineriE, CremaL, Dal ZoppoS, et al. (2010) Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. European Journal of Clinical Microbiology and Infectious Diseases 29: 1015–1024.
27. RaymondDP, PelletierSJ, CrabtreeTD, et al. (2001) Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Critical Care Medicine 29: 1101–1108.
28. SandiumengeA, DiazE, RodriguezA, et al. (2006) Impact of diversity of antibiotic use on development of antimicrobial resistance. Journal of Antimicrobial Chemotherapy 57: 1197–1204.
29. SandiumengeA, LisboaT, GomezF, HernandezP, CanadellL, et al. (2011) Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE Organisms. Chest 140: 643–651.
30. TakesueY, NakajimaK, IchikiK, et al. (2010) Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria. Journal of Hospital Infection 75: 28–32.
31. TakesueY, OhgeH, SakashitaM, et al. (2006) Effect of antibiotic heterogeneity on the development of infections with antibiotic-resistant gram-negative organisms in a nonintensive care unit surgical ward. World Journal of Surgery 30: 1269–1276.
32. YoungEJ, SewellCM, KozaMA, et al. (1985) Antibiotic resistance patterns during aminoglycoside restriction. American Journal of Medical Sciences 290: 223–227.
33. BariePS, HydoLJ, ShouJ, LaroneDH, EachempatiSR (2005) Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt) 6: 41–54.
34. BradleySJ, WilsonAL, AllenMC, et al. (1999) The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. Journal of Antimicrobial Chemotherapy 43: 261–266.
35. CraigM, CumpstonAD, HobbsGR, et al. (2007) The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. Bone Marrow Transplant 39: 477–482.
36. DortchMJ, FlemingSB, KauffmannRM, DossettLA, TalbotTR, et al. (2011) Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections. Surg Infect (Larchmt) 12: 15–25.
37. SlainD, SarwariAR, PetrosKO, McKnightRL, SagerRB, et al. (2011) Impact of a Multimodal Antimicrobial Stewardship Program on Pseudomonas aeruginosa Susceptibility and Antimicrobial Use in the Intensive Care Unit Setting. Crit Care Res Pract 2011: 416426.
38. WarrenDK, HillHA, MerzLR, et al. (2004) Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. Critical Care Medicine 32: 2450–2456.
39. MerzLR, WarrenDK, KollefMH, et al. (2006) The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Chest 130: 1672–1678.
40. Van LoonH, VriensM, FluitA, et al. (2005) Antibiotic rotation and development of Gram-negative antibiotic resistance. American Journal of Respiratory Critical Care Medicine 171: 480–487.
41. MossWJ, BeersMC, JohnsonE, et al. (2002) Pilot study of antibiotic cycling in a pediatric intensive care unit. Critical Care Medicine 30: 1877–1882.
42. PakyzALBMF (2009) Rates of Stenotrophomonas maltophilia colonization and infection in relation to antibiotic cycling protocols. Epidemiology and Infection 137: 1679.
43. HashinoS, MoritaL, KanamoriH, TakahataM, OnozawaM, et al. (2012) Clinical impact of cycling the administration of antibiotics for febrile neutropenia in Japanese patients with hematological malignancy. Eur J Clin Microbiol Infect Dis 31: 173–178.
44. Bruno-MurthaLA, BruschJ, BorD, et al. (2005) A pilot study of antibiotic cycling in the community hospital setting. Infection Control Hospital Epidemiology 26: 81–87.
45. BennettKM, ScarboroughJE, SharpeM, et al. (2007) Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. Journal of Trauma 63: 307–311.
46. GerdingDN, LarsonTA, HughesRA, et al. (1991) Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrobial Agents and Chemotherapy 35.
47. GrusonD, HilbertG, VargasF, et al. (2000) Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibioticresistant Gram-negative bacteria. American Journal of Respiratory Critical Care Medicine 162: 837–843.
48. GrusonD, HilbertG, VargasF, et al. (2003) Strategy of antibiotic rotation: long term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.∧. Critical Care Medicine 31: 1908–1914.
49. CadenaJ, TaboadaCA, BurgessDS, MaJZ, LewisJS2nd, et al. (2007) Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit. Bone Marrow Transplant 40: 151–155.
50. HedrickTL, SchulmanAS, McElearneyST, et al. (2008) Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen. Surgical Infections 9: 139–152.
51. KhederSI, EltayebI, ShaddadSA, AlKhedirI (2012) Optimizing Antimicrobial Drug Use in Surgery: An Intervention Strategy in A Sudanese Hospital to Combat The Emergence of Bacterial Resistant. Sudan Journal of Medical Sciences 6.
52. NijssenS, FluitA, van de VijverD, et al. (2010) Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria. Intensive Care Medicine 36: 512–519.
53. ToltzisP, DulM, HoyenC, et al. (2002) The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit. Peaditrics 110: 707–711.
54. SmithRL, EvansHL, ChongTW, et al. (2008) Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolidvancomycin cycling in a surgical intensive care unit. Surgical Infections 9: 423–431.
55. GinnAN, WiklendtAM, GiddingHF, GeorgeN, O'DriscollJS, et al. (2012) The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection. PLoS One 7: e38719.
56. CumpstonA, CraigM, HamadaniM, AbrahamJ, HobbsGR, et al. (2013) Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit. Transpl Infect Dis 15: 142–149.
57. KontopidouFV, AntoniadouA, TsirigotisP, VenetisE, PolemisM, et al. (2013) The impact of an antimicrobial cycling strategy for febrile neutropenia in a haematology unit. J Chemother 25: 279–285.
58. Sarraf-YazdiS, SharpeM, BennettKM, DotsonTL, AndersonDJ, et al. (2012) A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit. J Surg Res 176: e73–78.
59. ChongY, ShimodaS, YakushijiH, ItoY, MiyamotoT, et al. (2013) Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. PLoS One 8: e54190.
60. MerzLR, WarrenDK, KollefMH, FraserVJ (2004) Effects on antibiotic cycling programon antibiotic prescribing practices in an intensive care unit. Antimicrobial Agents and Chemotherapy 48: 2861–2865.
61. BeardmoreRE, Pena-MillerR (2010) Antibiotic cycling versus mixing: the difficulty of using mathematical models to definitively quantify their relative merits. Math Biosci Eng 7: 923–933.
62. ChowK, WangX, CurtissR3rd, Castillo-ChavezC (2011) Evaluating the efficacy of antimicrobial cycling programmes and patient isolation on dual resistance in hospitals. J Biol Dyn 5: 27–43.
63. MartínezJA, NicolásJM, MarcoF, et al. (2005) Comparison of antimicrobial cycling and mixing in two medical intensive care units. Critical Care Medicine 34: 329–336.
64. KouyosRD, Abel Zur WieschP, BonhoefferS (2011) Informed switching strongly decreases the prevalence of antibiotic resistance in hospital wards. PLoS Comput Biol 7: e1001094.
65. ViechtbauerW (2010) Conducting meta-analyses in R with the metafor package. Journal of
66. BerkeyCS, HoaglinDC, Antczak-BouckomsA, MostellerF, ColditzGA (1998) Meta-analysis of multiple outcomes by regression with random effects. Stat Med 17: 2537–2550.
67. RileyRD, ThompsonJR (2008) An alternative model for bivariate random-effects meta-analysis when the within-study correlations are unknown. Biostatistics 9: 172–186.
68. RileyRD (2009) Multivariate meta-analysis: The effect of ignoring within-study correlation. Journal of the Royal Statistical Society, Series A 178: 789–811.
69. HigginsJP, ThompsonSG, DeeksJJ, AltmanDG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557–560.
70. EggerM, Davey SmithG, SchneiderM, MinderC (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629–634.
71. BeggCB, MazumdarM (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088–1101.
72. KouyosRD, Abel Zur WieschP, BonhoefferS (2011) On being the right size: the impact of population size and stochastic effects on the evolution of drug resistance in hospitals and the community. PLoS Pathog 7: e1001334.
73. NeelyAN, MaleyMP (2000) Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol 38: 724–726.
74. European Center for Disease Prevention and Control (2008) Annual Epidemiological Report on Communicable Diseases in Europe 2008. In: Control ECfDPa, editor. Stockholm.
75. LucianiF, SissonSA, JiangH, FrancisAR, TanakaMM (2009) The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 106: 14711–14715.
76. TrindadeS, SousaA, XavierKB, DionisioF, FerreiraMG, et al. (2009) Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet 5: e1000578.
77. JohnsenPJ, TownsendJP, BohnT, SimonsenGS, SundsfjordA, et al. (2011) Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures. J Antimicrob Chemother 66: 608–610.
78. DennesenPJ, van der VenAJ, KesselsAG, RamsayG, BontenMJ (2001) Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163: 1371–1375.
79. OttigerC, SchaerG, HuberAR (2007) Time-course of quantitative urinary leukocytes and bacteria counts during antibiotic therapy in women with symptoms of urinary tract infection. Clin Chim Acta 379: 36–41.
80. GrundmannH, HellriegelB (2006) Mathematical modelling: a tool for hospital infection control. Lancet Infect Dis 6: 39–45.
81. BootsmaMC, WassenbergMW, TrapmanP, BontenMJ (2011) The nosocomial transmission rate of animal-associated ST398 meticillin-resistant Staphylococcus aureus. J R Soc Interface 8: 578–584.
82. BontenMJ, HaydenMK, NathanC, RiceTW, WeinsteinRA (1998) Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis 177: 378–382.
83. McFarlandLV, MulliganME, KwokRY, StammWE (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320: 204–210.